Is Immunitybio Inc (IBRX) Stock About to Get Hot Friday?

The market has been high on Immunitybio Inc (IBRX) stock recently. IBRX gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Immunitybio Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on IBRX!

See Full IBRX Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With IBRX Stock Today?

Immunitybio Inc (IBRX) stock is up 3.73% while the S&P 500 is lower by -0.16% as of 10:47 AM on Friday, Mar 22. IBRX is up $0.23 from the previous closing price of $6.17 on volume of 1,955,911 shares. Over the past year the S&P 500 is up 32.92% while IBRX is up 292.64%. IBRX lost -$1.15 per share in the over the last 12 months. To screen for more stocks like Immunitybio Inc click here.

More About Immunitybio Inc

ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate (natural killer cell and macrophage) and adaptive (T cell) immune systems to create long-term immunological memory. Click Here to get the full Stock Report for Immunitybio Inc stock.